PPG Industries Inc., AkzoNobel N.V., Axalta Coating Systems LLC, Jotun A/S, Teknos Group Oy, Tulip Paints

Overview and Scope
Joint pain injections reduce inflammation and discomfort and are typically injected directly into the joint for pain relief. Joint pain is very frequent among the elderly or as a result of pre-existing medical problems or disorders. It can happen as a result of musculoskeletal illnesses such as arthritis, which causes pain and inflammation. The joint pain injections are used to relieve joint pain and inflammation quickly through non-surgical treatments.

Sizing and Forecast
The joint pain injections market size has grown rapidly in recent years. It will grow from $5.19  billion in 2023 to $5.75  billion in 2024 at a compound annual growth rate (CAGR) of 10.9%.  The  growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $8.8  billion in 2028 at a compound annual growth rate (CAGR) of 11.2%.  The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of InjectionS
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the joint pain injections market in 2023. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=6482&type=smp

Major Driver Impacting Market Growth

The rise in the prevalence of arthritis and musculoskeletal disorders will propel the growth of the joint pain injections market. Musculoskeletal disorders are the biggest cause of disability worldwide, with low back pain being the single most common cause of impairment in 160 nations. Patients are taking injections for pain relief and inflammatory condition. For instance, in February 2021, according to the report published by WHO, approximately 1.71 billion people in the world are affected by musculoskeletal conditions and the number of people with musculoskeletal disorders is continuously growing due to population growth and aging. Similarly, in 2021, according to the report by Global RA Network, arthritis affects about 350 million people worldwide and increasing rapidly. Therefore, the rising prevalence of arthritis and musculoskeletal disorder drives the joint pain injections market.

Key Industry Players

Major companies operating in the joint pain injections market include  Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

The joint pain injections market report table of contents includes:

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market – Macro Economic Scenario

…

31. Global Joint Pain Injections Market Competitive Benchmarking

32. Global Joint Pain Injections Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Joint Pain Injections Market Future Outlook and Potential Analysis